Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: A descriptive analysis
Authors: Ashra Kolhatkar, Lucy Cheng, Steven G. Morgan, Laurie J. Goldsmith, Irfan A. Dhalla, Anne M. Holbrook, and Michael R. Law
Background: Out-of-pocket drug costs lead many Canadians to engage in cost-related nonadherence to prescription medications, but our understanding of other consequences such as borrowing money remains incomplete. In this descriptive study, we sought to quantify the frequency of borrowing to pay for prescription drugs in Canada and characteristics of Canadians who borrowed money for this purpose. Methods: In partnership with Statistics Canada, we designed and administered a cross-sectional rapid-response module in the Canadian Community Health Survey administered by telephone to Canadians aged 12 years or more between January and June 2016. We restricted our analyses to participants who responded to the question regarding borrowing money to pay for prescription drugs and used logistic regression to identify characteristics associated with borrowing. Results: A total of 28 091 Canadians responded to the survey (overall response rate 61.8%). The weighted proportion of respondents who reported having borrowed money to pay for prescription drugs in the previous year was 2.5% (95% confidence interval 2.2%-2.8%), an estimated 731 000 Canadians. The odds of borrowing were higher among younger adults, people in poor health and people lacking prescription drug insurance. Other factors associated with increased adjusted odds of borrowing were having 2 or more chronic conditions, low household income and higher out-of-pocket prescription drug costs. Interpretation: Many Canadians reported borrowing money to pay for out-of-pocket prescription drug costs, and borrowing was more prevalent among already vulnerable groups that also report other compensatory behaviours to address challenges in paying for prescription drugs. Future research should investigate policy responses intended to increase equity in access to prescription drugs.
Please note that abstracts only appear in the language of the publication and might not have a translation.
Michael R. Law, Lucy Cheng, Ashra Kolhatkar, Laurie J. Goldsmith, Steven G. Morgan, Anne M. Holbrook, and Irfan A. Dhalla (2018).
The consequences of patient charges for prescription drugs in Canada: A cross-sectional survey
CMAJ Open , E63-E70
Stéphanie Harrison, Didier Brassard, Simone Lemieux, and Benoît Lamarche (2019).
Consumption and sources of saturated fatty acids according to the 2019 Canada Food Guide: Data from the 2015 Canadian Community Health Survey
Nutrients , 10-Jan
Norbert Schmitz, JianLi Wang, Ashok Malla, and Alain Lesage (2009).
The impact of psychological distress on functional disability in asthma: results from the Canadian community health survey
Psychosomatics , 42-49
Melissa K. Andrew, Arnold Mitnitski, and Kenneth Rockwood (2008).
Social vulnerability, frailty and mortality in elderly people
PLoS ONE , e2232
Sarah Brennenstuhl and Esme Fuller-Thomson (2015).
The painful legacy of childhood violence: Migraine headaches among adult survivors of adverse childhood experiences
Headache , 973-983
S. N. Vigod and D. E. Stewart (2006).
Major depression in female urinary incontinence
Psychosomatics , 147-151